Ophthalmology Devices Global Market – Forecast To 2021

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 20

2 INTRODUCTION 27

• 2.1 KEY TAKE AWAYS 27
• 2.2 REPORT DESCRIPTION 28
• 2.3 MARKETS COVERED 29
• 2.4 STAKEHOLDERS 32
• 2.5 RESEARCH METHODOLOGY 32
  • 2.5.1 MARKET SIZE ESTIMATION 34
  • 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 36
  • 2.5.3 SECONDARY SOURCES 37
  • 2.5.4 PRIMARY SOURCES 38
  • 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 38
  • 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 39
  • 2.5.7 ASSUMPTIONS 40

3 MARKET ANALYSIS 41

• 3.1 INTRODUCTION 41
• 3.2 MARKET SEGMENTATION 42
• 3.3 FACTORS INFLUENCING MARKET 44
  • 3.3.1 DRIVERS 45
    • 3.3.1.1 Increasing baby boomer population and incidence of degenerative diseases of eyes 45
    • 3.3.1.2 Increase in r&d activities by ophthalmology key players 45
    • 3.3.1.3 Extensive use of high-end technologies involving use of software and computer aided devices and platforms 46
    • 3.3.1.4 Untapped emerging markets 46
    • 3.3.1.5 Development of minimal invasive surgery 47
  • 3.3.2 RESTRAINTS 47
    • 3.3.2.1 Lack of ophthalmologists 47
    • 3.3.2.2 Economic slowdown and saturation of the market in developed

  countries 48

  • 3.3.2.3 Reimbursement cuts 48
• 3.3.3 THREATS 49
  • 3.3.3.1 Intensified competition 49
• 3.3.4 CHALLENGES 49
  • 3.3.4.1 Lack of insurance coverage in developing countries and insufficient coverage for iols in developed countries 49
  • 3.3.4.2 Extended timelines of device approval 50

4 GLOBAL OPHTHALMOLOGY DEVICES MARKET, BY PRODUCTS 75

• 4.1 INTRODUCTION 75
  • 4.1.1 GLOBAL OPHTHALMOLOGY DIAGNOSTIC DEVICES BY PRODUCT TYPES 76
    • 4.1.1.1 Autorefractors 80
    • 4.1.1.2 Slit lamp 82
    • 4.1.1.3 Tonometer 84
    • 4.1.1.4 Ophthalmoscope 86
    • 4.1.1.5 Keratometer 88
    • 4.1.1.6 Corneal topographer 90
    • 4.1.1.7 Optical coherence tomography (OCT) 92
    • 4.1.1.8 Fundus camera 94
    • 4.1.1.8.1 Non-mydriatic fundus cameras 98
    • 4.1.1.8.2 Mydriatic fundus cameras 99
    • 4.1.1.8.3 Hybrid fundus cameras 100
    • 4.1.1.8.4 Retinopathy of prematurity (ROP) 102
    • 4.1.1.9 Ophthalmic ultrasound imaging system 103
    • 4.1.1.10 Retinoscope 105
    • 4.1.1.11 Perimeter 107
    • 4.1.1.12 Pachymeter 109
    • 4.1.1.13 Others 111
    • 4.1.1.13.1 Snellen chart 112
    • 4.1.1.13.2 Amsler grid eye test 112
    • 4.1.1.13.3 Wavefront aberrometer 113
    • 4.1.1.13.4 Point of care devices 113
    • 4.1.2 GLOBAL OPHTHALMIC SURGICAL DEVICES MARKET 115
      • 4.1.2.1 Introduction 115
      • 4.1.2.2 Cataract surgery devices 119
      • 4.1.2.2.1 Intraocular lens (IOL) 122
      • 4.1.2.2.2 Phacoemulsification 125
      • 4.1.2.2.3 OVDS (OPHTHALMIC VISCOSURGICAL DEVICES) 127
      • 4.1.2.2.4 YAG Laser 129
      • 4.1.2.3 Glaucoma surgery devices 129
      • 4.1.2.3.1 Glaucoma lasers 131
      • 4.1.2.3.2 Glaucoma surgery 131
      • 4.1.2.3.3 Glaucoma implants 131
      • 4.1.2.3.4 Glaucoma systems 132
      • 4.1.2.4 Refractive error surgical devices 132
      • 4.1.2.4.1 Photorefractive keratectomy (PRK) 134
      • 4.1.2.4.2 Laser assisted sub-epithelium keratomileusis (LASEK) 134
      • 4.1.2.4.3 Laser assisted insitu keratomileusis (LASIK) 134
      • 4.1.2.4.4 Femtosecond laser 134
      • 4.1.2.4.5 Epi-LASIK 135
      • 4.1.2.4.6 Phakic intraocular lens (PIOLS) 136
      • 4.1.2.5 Vitreoretinal surgical devices 136
      • 4.1.2.5.1 Vitrectomy 137
      • 4.1.2.5.2 Photocoagulation 138
      • 4.1.2.5.3 Illumination 138
      • 4.1.3 GLOBAL VISION CARE DEVICES 139
        • 4.1.3.1 Introduction 139
        • 4.1.3.2 Spectacle lenses 142
        • 4.1.3.3 Contact lenses 144

      5 OPHTHALMOLOGY DEVICES GLOBAL MARKET, BY APPLICATIONS 147

      • 5.1 INTRODUCTION 147
      • 5.2 CATARACT 150
      • 5.3 GLAUCOMA 153
      • 5.4 AGE RELATED MACULAR DEGENERATION 155
      • 5.5 DIABETIC RETINOPATHY (DR) 157
      • 5.6 OTHERS (REFRACTIVE ERRORS, AMBLYOPIA, STRABISMUS) 160

      6 OPHTHALMOLOGY DEVICES GLOBAL MARKET, BY END-USERS 162

      • 6.1 INTRODUCTION 162
      • 6.2 HOSPITALS 165
      • 6.3 ACADEMIC & RESEARCH LABORATORIES 167
      • 6.4 OTHERS 169

      7 REGIONAL ANALYSIS 171

      • 7.1 INTRODUCTION 171
      • 7.2 NORTH AMERICA 173
        • 7.2.1 U.S. 174
        • 7.2.2 CANADA 175
      • 7.3 EUROPE 185
      • 7.4 ASIA PACIFIC 195
      • 7.5 REST OF THE WORLD 205

      8 COMPANY DEVELOPMENTS 215

      • 8.1 INTRODUCTION 215
      • 8.2 NEW PRODUCT LAUNCHES 216
      • 8.3 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES 222
      • 8.4 APPROVALS 225
      • 8.5 MERGERS & ACQUISITIONS 229

      9 MAJOR COMPANIES 232

      • 9.1 ABBOTT LABORATORIES 232
        • 9.1.1 OVERVIEW 232
        • 9.1.2 FINANCIALS 233
        • 9.1.3 PRODUCT PORTFOLIO 236
        • 9.1.4 KEY DEVELOPMENTS 240
        • 9.1.5 BUSINESS STRATEGY 241
        • 9.1.6 SWOT ANALYSIS 242
      • 9.2 NOVARTIS AG 243
        • 9.2.1 OVERVIEW 243
        • 9.2.2 FINANCIALS 244
        • 9.2.3 PRODUCT PORTFOLIO 247
        • 9.2.4 KEY DEVELOPMENTS 249
        • 9.2.5 BUSINESS STRATEGY 251
        • 9.2.6 SWOT ANALYSIS 251
      • 9.3 VALEANT PHARMACEUTICALS INTERNATIONAL, INC 252
        • 9.3.1 OVERVIEW 252
        • 9.3.2 FINANCIALS 253
        • 9.3.3 PRODUCT PORTFOLIO 255
        • 9.3.4 KEY DEVELOPMENTS 258
        • 9.3.5 BUSINESS STRATEGY 262
        • 9.3.6 SWOT ANALYSIS 263
      • 9.4 CARL ZEISS AG 264
        • 9.4.1 OVERVIEW 264
        • 9.4.2 FINANCIALS 265
        • 9.4.3 PRODUCT PORTFOLIO 268
        • 9.4.4 KEY DEVELOPMENTS 273
        • 9.4.5 BUSINESS STRATEGY 274
        • 9.4.6 SWOT ANALYSIS 275
      • 9.5 ESSILOR INTERNATIONAL 276
        • 9.5.1 OVERVIEW 276
        • 9.5.2 FINANCIALS 277
        • 9.5.3 PRODUCTS PORTFOLIO 279
        • 9.5.4 KEY DEVELOPMENTS 281
        • 9.5.5 BUSINESS STRATEGY 285
        • 9.5.6 SWOT ANALYSIS 285
      • 9.6 HAAG-STREIT HOLDING AG. 286
        • 9.6.1 OVERVIEW 286
        • 9.6.2 FINANCIALS 287
        • 9.6.3 PRODUCT PORTFOLIO 287
        • 9.6.4 KEY DEVELOPMENTS 290
        • 9.6.5 BUSINESS STRATEGY 290
        • 9.6.6 SWOT ANALYSIS 291
      • 9.7 HOYA CORPORATION 292
        • 9.7.1 OVERVIEW 292
        • 9.7.2 FINANCIALS 293
        • 9.7.3 PRODUCTS PORTFOLIO 296
        • 9.7.4 KEY DEVELOPMENTS 297
        • 9.7.5 BUSINESS STRATEGY 297
        • 9.7.6 SWOT ANALYSIS 298
      • 9.8 JOHNSON & JOHNSON 299
        • 9.8.1 OVERVIEW 299
        • 9.8.2 FINANCIALS 300
        • 9.8.3 PRODUCT PORTFOLIO 303
        • 9.8.4 KEY DEVELOPMENTS 304
        • 9.8.5 BUSINESS STRATEGY 304
        • 9.8.6 SWOT ANALYSIS 305
      • 9.9 NIDEK CO., LTD 306
        • 9.9.1 OVERVIEW 306
        • 9.9.2 FINANCIALS 306
        • 9.9.3 PRODUCT PORTFOLIO 307
        • 9.9.4 KEY DEVELOPMENTS 310
        • 9.9.5 BUSINESS STRATEGY 312
      • 9.10 STAAR SURGICAL COMPANY 313
        • 9.10.1 OVERVIEW 313
        • 9.10.2 FINANCIALS 314
        • 9.10.3 PRODUCT PORTFOLIO 317
        • 9.10.4 KEY DEVELOPMENTS 317
        • 9.10.5 BUSINESS STRATEGY 318
        • 9.10.6 SWOT ANALYSIS 319
      • 9.11 TOPCON CORPORATION 320
        • 9.11.1 OVERVIEW 320
        • 9.11.2 FINANCIALS 321
        • 9.11.3 PRODUCT PORTFOLIO 324
        • 9.11.4 KEY DEVELOPMENTS 326
        • 9.11.5 BUSINESS STRATEGY 326
        • 9.11.6 SWOT ANALYSIS 327

      LIST OF TABLES

      TABLE 1 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 23

      TABLE 2 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN) 24

      TABLE 3 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2013-2021) ($MN) 25

      TABLE 4 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2013-2021) ($MN) 26

      TABLE 5 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN) 76

      TABLE 6 DIAGNOSTIC DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 78

      TABLE 7 AUTOREFRACTOMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 81

      TABLE 8 SLIT LAMP GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 83

      TABLE 9 TONOMETERS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 85

      TABLE 10 OPHTHALMOSCOPE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 87

      TABLE 11 KERATOMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 89

      TABLE 12 CORNEAL TOPOGRAPHER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 91

      TABLE 13 OPTICAL COHERENCE TOMOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 93

      TABLE 14 FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 96

      TABLE 15 FUNDUS CAMERA GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 97

      TABLE 16 NON-MYDRIATIC FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 98

      TABLE 17 MYDRIATIC FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 100

      TABLE 18 HYBRID FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 101

      TABLE 19 RETINOPATHY OF PREMATURITY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 102

      TABLE 20 OPHTHALMIC ULTRASOUND IMAGING SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 104

      TABLE 21 RETINOSCOPE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 106

      TABLE 22 PERIMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 108

      TABLE 23 PACHYMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 110

      TABLE 24 OTHERS (DIAGNOSTICS) GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 111

      TABLE 25 SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 116

      TABLE 26 SURGICAL DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 117

      TABLE 27 CATARACT SURGICAL DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 120

      TABLE 28 CATARACT SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 121

      TABLE 29 IOL GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 124

      TABLE 30 PHACOEMULSIFICATION GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 126

      TABLE 31 OVD GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 128

      TABLE 32 GLACOMA SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 130

      TABLE 33 REFRACTIVE SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 133

      TABLE 34 VITREORETINAL SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 137

      TABLE 35 VISION CARE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 140

      TABLE 36 VISION CARE GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 141

      TABLE 37 SPECTACLE LENSES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 143

      TABLE 38 CONTACT LENSES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 146

      TABLE 39 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 149

      TABLE 40 CATARACT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 152

      TABLE 41 GLAUCOMA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 154

      TABLE 42 AGE RELATED MACULAR DEGENERATION MARKET REVENUE, BY REGION, (2013-2021) ($MN) 156

      TABLE 43 DIABETIC RETINOPATHY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 159

      TABLE 44 OTHERS (APPLICATIONS) GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 161

      TABLE 45 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2013-2021) ($MN) 164

      TABLE 46 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 166

      TABLE 47 ACADEMICS & RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 168

      TABLE 48 OTHER END USERS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 170

      TABLE 49 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN) 177

      TABLE 50 NORTH AMERICAN DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 178

      TABLE 51 NORTH AMERICAN FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 179

      TABLE 52 NORTH AMERICAN SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 180

      TABLE 53 NORTH AMERICAN CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 181

      TABLE 54 NORTH AMERICAN VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 182

      TABLE 55 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 183

      TABLE 56 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USER, (2013-2021) ($MN) 184

      TABLE 57 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 187

      TABLE 58 EUROPEAN DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 188

      TABLE 59 EUROPEAN FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 189

      TABLE 60 EUROPEAN SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 190

      TABLE 61 EUROPEAN CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 191

      TABLE 62 EUROPEAN VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 192

      TABLE 63 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 193

      TABLE 64 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN) 194

      TABLE 65 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 197

      TABLE 66 ASIA-PACIFIC DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 198

      TABLE 67 ASIA-PACIFIC FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 199

      TABLE 68 ASIA-PACIFIC SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 200

      TABLE 69 ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 201

      TABLE 70 ASIA-PACIFIC VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 202

      TABLE 71 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 203

      TABLE 72 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN) 204

      TABLE 73 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE (2013-2021) ($MN) 207

      TABLE 74 ROW DIAGNOSTICS DEVICES MARKET REVENUE, BY TYPES, (2013-2021) ($MN) 208

      TABLE 75 ROW FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 209

      TABLE 76 ROW SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 210

      TABLE 77 ROW CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 211

      TABLE 78 ROW VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 212

      TABLE 79 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 213

      TABLE 80 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN) 214

      TABLE 81 NEW PRODUCT LAUNCHES (2013-2015) 217

      TABLE 82 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES (2013-2015) 222

      TABLE 83 APPROVALS (2013-2015) 226

      TABLE 84 MERGERS & ACQUISITIONS (2013-2015) 229

      TABLE 85 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN) 233

      TABLE 86 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 234

      TABLE 87 ABBOTT LABORATORIES: REVENUE SEGMENTS OF MEDICAL DEVICES, (2013-2014)($MN) 235

      TABLE 88 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 236

      TABLE 89 NOVARTIS: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN) 244

      TABLE 90 NOVARTIS AG: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 245

      TABLE 91 NOVARTIS AG: SEGMENTAL REVENUE OF ALCON LABORATORIES, (2012-2014) ($MN) 246

      TABLE 92 NOVARTIS AG: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 247

      TABLE 93 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN) 253

      TABLE 94 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 254

      TABLE 95 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 255

      TABLE 96 CARL ZEISS AG: TOTAL SALES AND R&D EXPENSES (2012-2014) ($MN) 265

      TABLE 97 CARL ZEISS: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN) 266

      TABLE 98 CARL ZEISS: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN) 267

      TABLE 99 ESSILOR: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN) 277

      TABLE 100 ESSILOR INTERNATIONAL: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 278

      TABLE 101 ESSILOR INTERNATIONAL: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 279

      TABLE 102 HOYA CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN) 293

      TABLE 103 HOYA CORPORATION: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN) 294

      TABLE 104 HOYA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN) 295

      TABLE 105 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN) 300

      TABLE 106 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 301

      TABLE 107 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 302

      TABLE 108 STAAR SURGICAL COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN) 314

      TABLE 109 STAAR SURGICAL COMPANY: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 315

      TABLE 110 STAAR SURGICAL COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN) 316

      TABLE 111 TOPCON CORPORAION.: TOTAL SALES AND R&D EXPENSES (2012-2014) ($MN) 321

      TABLE 112 TOPCON CORPORATION: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN) 322

      TABLE 113 TOPCON CORPORATION: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN) 323

      LIST OF FIGURES

      FIGURE 1 GLOBAL OPHTHALMOLOGY DEVICES MARKET SHARE AND REVENUE, BY REGION (2013-2021) 22

      FIGURE 2 RESEARCH METHODOLOGY: OPHTHALMOLOGY DEVICES GLOBAL MARKET 33

      FIGURE 3 OPHTHALMOLOGY DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 34

      FIGURE 4 OPHTHALMOLOGY DEVICES MARKET: FORECASTING MODEL 35

      FIGURE 5 OPHTHALMOLOGY DEVICES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION 36

      FIGURE 6 OPHTHALMOLOGY DEVICES MARKET SEGMENTATION 43

      FIGURE 7 MARKET DYNAMICS 44

      FIGURE 8 OPHTHALMOLOGY DEVICES MARKET:PATENT FILING BY MAJOR PLAYERS (2010-2015) 59

      FIGURE 9 OPHTHALMOLOGY DEVICES MARKET:PATENT FILING BY SEGMENT, (2010-2015) 60

      FIGURE 10 OPHTHALMOLOGY DEVICES MARKET: PORTER’S ANALYSIS 69

      FIGURE 11 OPHTHALMOLOGY DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014 72

      FIGURE 12 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2014 V’S 2021) ($MN) 79

      FIGURE 13 GLOBAL OPHTHALMOLOGY DEVICE MARKET REVENUE, BY SURGERY (2014 V’S 2021) ($MN) 118

      FIGURE 14 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION (2014 V’S 2021) ($MN) 148

      FIGURE 15 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END USERS (2013 V’S 2021) ($MN) 163

      FIGURE 16 GLOBAL OPHTHALMOLOGY DEVICES MARKET REVENUE, BY REGION (2013-2021) ($MN) 172

      FIGURE 17 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021) 176

      FIGURE 18 EUROPEAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021) 186

      FIGURE 19 ASIA-PACIFIC OPHTHMOLOGY DEVICES MARKET SIZE, BY TYPE, PRODUCT, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021) 196

      FIGURE 20 ROW OPHTHMOLOGY DEVICES MARKET SIZE, BY TYPE, PRODUCT, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021) 206

      FIGURE 21 KEY GROWTH STRATEGIES, (2013-2015) 216

      FIGURE 22 SWOT: ABBOTT LABORATORIES 242

      FIGURE 23 SWOT: ALCON LABORATORIES. 251

      FIGURE 24 SWOT: VALEANT PHARMACEUTICALS INTERNATIONAL 263

      FIGURE 25 SWOT: CARL ZEISS 275

      FIGURE 26 SWOT: ESSILOR INTERNATIONAL 285

      FIGURE 27 SWOT: HAAG-STREIT AG 291

      FIGURE 28 SWOT: HOYA CORPORATION 298

      FIGURE 29 SWOT: JOHNSON & JOHNSON 305

      FIGURE 30 SWOT: STAAR SURGICAL COMPANY 319

      FIGURE 31 SWOT: TOPCON CORPORATION 327

      LIST OF ACRONYMS

      Acronym Expanded form

      AAO America Academy of Ophthalmology

      AAPOS American Association of Paediatric Ophthalmology and Strabismus

      AIMDD Active Implantable Medical Device Directive

      AMD Age Related Macular Degeneration

      AMO Abbott Medical Optics

      B&L Bausch and Lomb

      CDC Centre for Disease Control and Development

      CDRH Centre for Devices and Radiological Health

      CDSCO Central Drug Standard Control Organization

      CE Conformity Europeans

      CFDA China Food and Drug Administration

      CLAA Central Licensing Approval Authority

      CLAO Contact Lens Association of Ophthalmologists

      CMOs Contract Manufacturing Organization

      CROs Contract Research Organizations

      CTS Common Technical Specifications

      DME Diabetic Macular Edema

      DR Diabetic Retinopathy

      DWFS Deconvolution Wave front Sensing

      EIU Economist Intelligence Unit

      EU European Union

      FDA Food and Drug Administration

      FFA Fundus Fluorescien Angiography

      GMP Good Manufacturing Practice

      GPOs Group Purchasing Organizations

      GRF Glaucoma Research Foundation

      HHS Department of Health and Human Services

      HPO High Performance Optics

      ICEH International Center for Eye Health

      ICO International Council of Ophthalmology

      IOL Intraocular Lenses

      IOP Intraocular Pressure

      JMDN Japan Medical Device Nomenclature

      JOIA Japan Ophthalmic Instruments Association

      LAL Light Adjustable Lens

      LASEK Laser Assisted Sub-Epithelium Keratomileusis

      LASIK Laser Assisted Insitu Keratomileusis

      LATAM Latin America

      LCD Liquid Crystal Display

      LED Light Emitting Diodes

      MAH Market Authorization Holder

      MDD Medical Device Directive

      MHLW Ministry of Health, Labor and Welfare

      MIGS Minimal Invasive Glaucoma Surgery

      MPF Medicare Physician Fee

      OAG Open-Angle Glaucoma

      OCT Optical Coherence Tomography

      ODE Office of Device Evolution

      OECD Organization of Economic Cooperation and Development

      OEM Original Equipment Manufacturers

      OVD Ophthalmic Viscoelastic Devices

      PAL Pharmaceutical Affairs Law

      PIOL Phakic Intraocular Lens

      PMA Pre Market Approval

      PMDA Pharmaceutical and Medical Devices Agency

      PPACA Patient Protection and Affordable Care Act

      PRK Photorefractive keratectomy

      QS Quality System

      R&D Research and Development

      RCB Registered Certified Body

      RK Radial Keratotomy

      RLE Refractive Lens Exchange

      ROP Retinopathy of Prematurity

      RoW Rest of the World

      SD-OCT Spectral Domain Optical Coherence Tomography

      SEC Security and Exchange Commission

      SFDA State Food and Drug Administration

      SOE European Society of Ophthalmology

      STED Summary Technical Document

      U.S. United States of America

      UK United Kingdom

      UV Ultra-Violet

      VEGF Vascular Endothelial Growth Factor

      VST Vision Shaping Treatment

      WHO World Health Organization

      1